Mirakhur R K, Dundee J W, Clarke R S
Br J Anaesth. 1977 Aug;49(8):825-9. doi: 10.1093/bja/49.8.825.
Glycopyrrolate, a new anticholinergic agent, was evaluated and compared with atropine. Glycopyrrolate 0.2 mg to neostigmine 1.0 mg was found to be safe and effective. The heart rates remained more stable with glycopyrrolate, and the frequency of arrhythmia, which was both transient and of no consequence, was similar in the two groups. The antisialogogue action of glycopyrrolate was superior to that of atropine.
格隆溴铵是一种新型抗胆碱能药物,对其进行了评估并与阿托品作比较。结果发现,0.2毫克格隆溴铵与1.0毫克新斯的明联用安全有效。使用格隆溴铵时心率保持更稳定,两组的心律失常发生率相似,均为短暂性且无严重后果。格隆溴铵的抑制唾液分泌作用优于阿托品。